Hotchkis & Wiley's value fund outperformed benchmarks in 2025, with FedEx highlighted as a key contributor. The logistics giant's shares rose over 20% in the past year, buoyed by strong domestic package performance, even as the fund remains selective in a top-heavy market.
CNBC's Jim Cramer highlights supply constraints as the primary force behind Western Digital's stock surge, even as analysts raise price targets. The commentary links the storage maker's fortunes to broader semiconductor and AI trends.
Damascus residents face electricity bills exceeding their monthly incomes after a massive government price hike, sparking rare public protests and deepening the crisis for a war-weary population.
Alphabet's stock surge, driven by its successful integration of AI, has investors weighing whether its current valuation still offers a compelling entry point for long-term growth.
A landmark trade agreement secured during Prime Minister Keir Starmer's visit to Beijing will see Chinese import duties on Scotch whisky cut from 10% to 5%, effective immediately. The move, hailed by industry leaders, is projected to inject £250 million into the UK economy and boost competitiveness in a key growth market.
SoFi Technologies smashed Wall Street's Q4 2025 revenue and profit forecasts, sending its shares sharply higher. However, the digital finance leader's shockingly weak sales outlook for the coming quarter has injected significant uncertainty into its growth narrative.
A new industry analysis reveals the apparel and textiles sector is falling dangerously behind on its climate commitments, with progress too slow to meet critical international targets.
HSBC has cut its price target for AI infrastructure firm CoreWeave, warning that rising borrowing costs and significant future funding needs could strain the high-flying company's financial runway.
Shares of Axos Financial (AX) have surged, closing at $94.64 and delivering strong returns over multiple timeframes. This momentum has reignited the debate among investors: is the stock still undervalued against its fair value estimate of $100.50, or has the market already priced in its future growth?
U.S. stock index futures trimmed early declines after President Donald Trump nominated former Fed governor Kevin Warsh to lead the central bank, a move seen as injecting moderate policy views amid economic uncertainty.
Geopolitical shifts and capacity constraints are positioning Intel Foundry as a potential strategic supplier for tech giants Apple and Nvidia by the end of the decade, according to industry reports.
German automotive giant Bosch reports a sharp 45% drop in operating profit for 2025, driven by heavy restructuring charges, intense global competition, and delayed returns on future-tech investments.
Former President Trump claims tariff revenue can fund direct payments to Americans, bypassing Congress. Experts question the legality and economic feasibility of the proposal.
Federal prosecutors unseal indictments against the CEO and senior vice president of First Brands Group, alleging a complex financial fraud that contributed to the company's recent bankruptcy.
Baldwin Insurance Group (BWIN) shares have faced significant pressure, dropping over 13% in a week. With a one-year loss of 45%, investors are questioning if the sell-off presents a buying opportunity or signals deeper issues. Our analysis digs into the valuation debate and key risks.
SkyWest Inc. reported robust full-year 2025 financials and announced multi-year contract extensions with United and Delta for its E175 aircraft, reinforcing its strategic position as a leading regional carrier partner amid ongoing industry shifts.
The Louisiana-based bank holding company declares a $0.15 per share dividend payable in February, as analysts project strong earnings growth and a sustainable payout ratio.
Despite a post-transition share price dip, Berkshire Hathaway's unique ecosystem of cash-generating assets, a colossal insurance 'float,' and a discounted valuation suggest the conglomerate is built to last, even without its legendary leader.
Eli Lilly commits $85 million upfront and over $1.8 billion in potential milestones to partner with Repertoire Immune Medicines, aiming to develop a new class of 'tolerizing' therapies that reset the immune system without broad suppression.
Timberland Bancorp (NASDAQ:TSBK) announces a dividend increase to $0.29 per share, reflecting sustained profitability and a commitment to shareholder returns. The move aligns the regional bank's yield with industry averages while maintaining a conservative payout ratio.
